Basic Information
| LncRNA/CircRNA Name | SNHG20 |
| Synonyms | NA |
| Region | GRCh38_17:77086716-77094990 |
| Ensemble | ENSG00000234912 |
| Refseq | NR_027058 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | qRT-PCR, Western blotting |
| Sample | tissue and serum specimens,cell lines (A549, NCI-H520, and H1299) |
| Expression Pattern | up-regulated |
| Function Description | LncRNA SNHG20 was highly expressed in the cancer tissues and serum of patients with NSCLC. LncRNA SNHG20 could promote the proliferation and inhibit the apoptosis of NSCLC cells. LncRNA SNHG20 could bind to micro RNA (miR)-197 in a targeted manner. |
| Pubmed ID | 31957836 |
| Year | 2020 |
| Title | Effects of lncRNA SNHG20 on Proliferation and Apoptosis of Non-Small Cell Lung Cancer Cells Through Wnt/?-catenin Signaling Pathway |
External Links
| Links for SNHG20 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |